FB2026_03 , released September 17, 2026
Reference Report
Open Close
Reference
Citation
Mehringer, J., Navarro, J.A., Touraud, D., Schneuwly, S., Kunz, W. (2022). Phosphorylated resveratrol as a protein aggregation suppressor in vitro and in vivo.  RSC Chem Biol 3(2): 250--260.
FlyBase ID
FBrf0253113
Publication Type
Research paper
Abstract
The stability of proteins in solution poses a great challenge for both technical applications and molecular biology, including neurodegenerative diseases. In this work, a phosphorylated resveratrol material was examined for its anti-aggregation properties in vitro and in vivo. Here, an anti-fibrillation effect could be measured for amyloid beta and human insulin in vitro and general anti-aggregation properties for crude chicken egg white in solution. Using a drosophila fly model for the overexpression of amyloid beta protein, changes in physiological protein aggregation and improved locomotor abilities could be observed in the presence of dietary phosphorylated resveratrol.
PubMed ID
PubMed Central ID
PMC8826510 (PMC) (EuropePMC)
Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    RSC Chem Biol
    Title
    RSC chemical biology
    ISBN/ISSN
    2633-0679
    Data From Reference
    Alleles (4)
    Genes (2)
    Insertions (1)
    Transgenic Constructs (3)